Nuclear Medicine and Biology

Papers
(The median citation count of Nuclear Medicine and Biology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter48
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation34
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry28
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.25
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging25
Simple method for the production of [11C]phosgene21
PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models20
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism18
Synthesis of [11C]Me-DPA and evaluation in transgenic mouse model of Alzheimer’s disease18
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/18
Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India17
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-6416
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics16
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-18816
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-7415
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors14
Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-6413
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks12
Editorial Board12
Status of radiobiology in molecular radionuclide therapy – Hope for the future12
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy12
Copper-mediated 18F-fluorination of boroxines: a systematic optimization study12
Electroamalgamation-and Chromatography-Based Eu/Tb Separation Procedures as a Proof of Concept for Separating 155Tb from Alpha-Irradiated 153Eu11
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information11
Development of an Automated [18F]FBPA Synthesis Using a Commercially Available Precursor11
Protocol for Automated Production of Radiofluorinated Boramino Acids11
18F-labelling of T cells for in vivo evaluation of CAR T cell therapy11
Impact of Different 177Lu Sources and Precursor Variations on the Quality of 177Lu-Labeled Theranostics11
Radiosynthesis and first in vitro evaluation of [11C]Onalespib for Hsp90 cancer imaging10
Preclinical and Initial Clinical Evaluation of 68Ga/177Lu-Labeled Heterodimer Agents Targeting both Somatostatin Receptor and Integrin αVβ310
Enhancing Tumor Uptake Efficiency of Radioimmunoconjugates through DLS-Based Aggregation Detection and Removal10
A new, optimised diphosphine chemical platform for kit-based, receptor-targeted 99mTc and 188Re radiopharmaceuticals10
A fully automated synthesis of [18F]Fluro-L-meta-tyrosine (FMT) on AllInOne synthesizer10
Optimization and Routine Production of Gallium-68-Radiolabeled Agents Using a Cyclotron Liquid Target System and Automated Radiosynthesis10
Domestic Production of Therapeutic Isotopes Via Fusion9
Evaluation of Antibody-Based TREM2 PET in Mice: Contrasting Image-Derived Blood Normalization with the Standard %ID Normalization Method9
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes9
Medical Radionuclide Production Using Nuclear Fusion9
Radiosynthesis of Primary Amides Through 11C-Carbonylation by [11C]Carbon Monoxide Using GE FX Synthesis Modules9
Radiolabeling yield dependency of post-dry distillation decay of astatine-2119
ATP Synthase is a Promising Target for Non-Invasive Imaging of Activated and Non-activated Adipose Tissues9
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N9
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody9
Rhenium and technetium complexes in extremely low oxidation states8
Non-invasive imaging of neutrophils in acute sepsis8
Mitochondria-targeted radiocomplexes for cancer theranostics8
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response8
89Zr-immuno-PET guided preclinical development of targeted therapies: demonstrating utility by evaluating fusion proteins in vivo8
Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain8
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen8
Next generation copper complexes for efficient production of radiolabeled aromatics7
Site-selective 18F-labelling of octreotide via disulfide rebridging7
Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide7
What a difference an additional methylene makes: replacing Glu with Aad in the Lys-urea-Glu pharmacophore to reduce kidney and salivary gland uptake of PSMA-targeting radiopharmaceuticals7
[68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging7
Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide7
Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE7
Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor7
[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor7
177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours6
Editorial Board6
An efficient, versatile procedure for the [18F]-radiofluorination of base-sensitive tracers with high radiochemical conversion6
[89Zr]ZrTrastuzumab automatic preparation on commercial cassette base synthesis module6
Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis6
Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM36
Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A96
Design and Preclinical Evaluation of 68Ga-Labeled Covalently Modified Nectin-4 Targeting Peptide as a Potential Tumor Radiotracer6
The theranostic Goldilocks radionuclide copper-67 produced at a biomedical cyclotron6
Translation of [68Ga]Ga-PSMA-11 radiosynthesis on the microfluidic system iMiDEVTM6
Development of Electrolytic Labeling of 211At to Iodotyrosine Derivatives6
A novel bispecific antibody for the enhanced delivery of radiopharmaceuticals to brain tumours6
The development of [18F]-LQ-1-41 as a PET tracer for imaging KRAS G12D tumors5
Imaging Glucose Metabolism and Dopaminergic Dysfunction in Sheep (Ovis aries) Brain Using Positron Emission Tomography Imaging Reveals Abnormalities in OVT73 Huntington’s Disease Sheep5
Validation of an HPLC method for assessing the chemical and radiochemical purity of [18F]Sodium Fluoride radiopharmaceutical5
18F-MGX-110S detects proinflammatory innate immune responses in human cells and Alzheimer’s disease mice with high sensitivity5
Non-Canonical Amino Acids Substitutions Modulate Biodistribution and Tumor Accumulation of FAP-Targeted Cyclic-peptide Radiotracers5
Surface Marker Diversity on Circulating Tumor Cells in Advanced Prostate Cancer Patients5
Fully automated and optimized [68Ga]Ga-NODAGA-Exendin-4 radiolabelling process on the TRASIS miniAllinOne5
Evaluation of [18F]TzPheBF3 cell uptake and intracellular iEDDA reactivity through in vitro studies using Hoechst-TCO5
Development of an HCAR1 radiotracer5
Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II5
Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model4
Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach4
Editorial Board4
Expression of concern “cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production“4
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH4
Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction4
[55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma4
Girentuximab (TLX250) as a theranostic tool in triple-negative breast cancer treatment4
Combining High-Throughput Radiochemical Experimentation Techniques with “Design of Experiments” (DoE) to Accelerate the Radiosynthesis Optimization of Novel Radiopharmaceuticals4
Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study4
GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP14
Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging4
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information4
Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt4
New prospects for 89Zr-immuno-PET in brain applications – Alpha-synucleinopathies4
Title Page4
Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging3
Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer3
Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 23
Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer3
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity3
Brain energetics by biomedical modalities3
Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production3
Targeted Alpha Therapy of Ovarian Cancer with ²¹²Pb-Labeled Anti-PTK7 Antibody: Efficient Production at Non-Clinical Scale and Preclinical Insights3
Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer3
Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis3
Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study3
Current developments in the production of actinium-225 from thorium-2293
Abstract withdrawn.3
Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne3
Synthesis/radiosynthesis and evaluation of three 18F radiotracers for imaging of sphingosine-1-phosphate receptor 13
Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results3
Comparison of biodistribution according to administration route for the development of liposome therapeutics3
Editorial Board3
Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging3
Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans2
Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R)2
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids2
Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages2
Development of Astatine-211 labeling reaction using aryliodonium ylide2
225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates2
Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery2
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands2
Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET2
Target occupancy studies of rho-associated protein kinase inhibitors in nonhuman primate with [11C]ROCK201 PET2
Recent advances in understanding and improving the stability of 211At-radiopharmaceuticals2
Radioactive Isotopes for Cancer Radiotherapy2
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information2
Synthesis of a new 6-substituted 4-anilinoquinazoline derivative as irreversible inhibitor for EGFR imaging2
Automated Purification of 64Cu with the GE FastLab For GMP Production2
Cancer stem cell targeted short peptide for PET imaging using Cu-64 in breast cancer cell xenografted model2
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties2
The development of terbium-155 and terbium-161 towards radiotheragnostic clinical applications2
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy2
Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS2
Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents2
Evaluation of chelating agents based on pyridine-azacrown compounds H4PATA, PATAM, and H4PATPA for 68Ga and 177Lu2
Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform2
2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation2
Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?2
Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging2
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold2
The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics2
Radio-HPLC for 225Ac-Radiopharmaceuticals: Considerations on the Retrospective Reconstruction of the 225Ac-Specific Radio-Chromatogram by Three Different Methods2
Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers2
Comparative radiobiology of human leukemia cells and opportunistic fungal cells post treatment with 225Ac- and 177Lu-radiolabeled antibodies2
Design of innovative FAP-target modules for simultaneous delivery of CAR-T cell-and radiotherapy2
Synthesis of Bifunctional Macrocyclic Chelator2
8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor2
Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors2
Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN2
Novel Radiofluorinated Analogues of GSK321 for PET Imaging of mIDH1 in Gliomas2
Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma2
Editorial Board2
Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain2
Development of small molecule PET-tracers targeting PD-L12
Corticolimbic activation patterns during aversive audiogenic stress assessed by cerebral perfusion using [99mTc]HMPAO SPECT/CT2
Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors2
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells2
Influence of radiolysis on astatine-211 chemistry2
A decade of ubiquicidin development for PET imaging of infection: A systematic review2
In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor2
Demonstrating targeted delivery of an antisense oligonucleotide (ASO) to pancreatic insulin secreting-cells in non-human primates using positron emission tomography2
89Zr-radiolabeling of p-NCS-Bz-DFO-anti-HER2 affibody immunoconjugate and in vitro assessment of its potential in HER2+ breast cancer imaging2
In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast canc2
Evaluation of 18F-Fluorosulfurylated Fluorescein Derivatives as Hybrid PET/Optical Imaging Agents1
Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience1
Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography1
Preliminary in vitro evaluation of synaptic density with [3H]UCB-J and the pan-tau ligand [3H]OXD-2314 in chronic traumatic encephalopathy.1
Evaluation of 177Lu-DOTA-obinutuzumab as a new radionuclide therapeutic agent for CD20-expressing non-Hodgkin lymphoma1
Development of [18F]DASA-10 for enhanced imaging of pyruvate kinase M21
Production of no-carrier-added holmium-166 by double neutron capture reaction at McMaster University research reactor1
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives1
Design of novel FAPI Target Modules for simultaneous diagnostic imaging, endoradiotherapy, and UniCAR T-cell immunotherapy1
Ultra-fast and efficient conversion of [11C]CO2 into [11C]hydantoins via the Bucherer-Bergs multicomponent reaction1
ImmunoPET for mesothelin positive tissues using bio-orthogonal in-vivo click chemistry1
Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module1
Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases1
Editorial Board1
Investigational Studies on Imaging CSF-1 Receptors in the Brain1
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist1
Evaluation of Direct and Pretargeting Approaches for CD38 PET Imaging in NSCLC Mouse Model with Isatuximab Fragment1
Utilizing click chemistry for PET infection imaging by fluorine-18 labeling of azide-modified bacteria1
The development of [11C]M503-1619 as a PET tracer for imaging α-synucleinopathies in Parkinson’s disease (PD)1
development of novel fap inhibitors for cancer imaging and therapy: from rapid uptake to prolonged retention1
Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma1
Corrigendum to “radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans” [nuclear medicine and biology, 144–145 (2025); 109,011]1
Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 d1
Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists1
Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation1
Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations1
103Ru/103mRh Auger electron emitter generator: a proof of concept1
Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker1
Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor1
Screening of mitochondrial dysfunction imaging radiopharmaceutical by targeting NDUFS1 using GCN and LSTM network1
Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections1
Filtration of Blood for Radiometabolite Analysis in Human Subjects1
Determination of sorption limit values of ion exchange resins used in the production of yttrium chloride Y-901
Imaging with Nanobody-based bimodal PET/fluorescence tracers for improved clinical decision making1
The development of a new type 103Pd/103mRh generator like cold brew coffee1
A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB1
Comparative evaluation of radiolabeled bombesin analogs [177Lu]Lu-AMBA and [177Lu]Lu-RM2 for targeting GRPR in glioblastoma model1
Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry1
Imaging and targeting S1PR1 in HER2+ tumors1
Quality assessment of cyclotron-produced 67Cu1
D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffold1
Large Chelators for Large Radiometals: Endeavors to Complex Radium-223 and Barium-131 to Advance Targeted Alpha Therapy and Theranostics of Cancer1
Characterization of a new Cu selective resin for the separation of Cu from Ni and Zn targets1
Enhanced tumor retention of the novel LAT1-targeting PET probe [18F]FAMT-OMe: A comparative study with [18F]FAMT in glioma mouse models1
Preclinical evaluation of two new neutrophil elastase inhibitors synthesized by palladium-mediated [11C]cyanations1
CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes1
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer1
Imaging resistance to anti-androgens in prostate cancer by multimodal 13C-pyruvate hyperpolarized magnetic resonance spectroscopy and 18F-pivalate positron emission tomography1
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG1
Synthesis of PET tracers for imaging of thiocyanate efflux from the brain1
PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis1
Metabolic profiling of mAChR ligands: In silico simulation vs LC-HRMS analysis1
Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies1
Development of noninvasive measurement for monoacylglycerol lipase activity in the brain using positron emission tomography1
Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography1
Editorial Board1
Enhancing anti-interleukin-6 antibody immunoPET and radiotherapy with chemotherapy1
Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer1
Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors1
Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts1
Optimal energy interval for the cyclotron production of 68Ga using solid targets1
Dopamine conjugation facilitates optical/PET imaging of polycations in vivo1
Scale up production and purification of high specific activity lead-203 (203Pb)1
Myocardial kinetics of [11C]β-hydroxybutyrate in healthy pigs: Comparison of positron emission tomography imaging vs. arteriovenous balance methods1
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis1
Development of Potential 18F-labelled Radiotracers for Imaging of Mutant Huntingtin Fibrils in Huntington’s Disease1
Targetry of 152Tb PET radioisotope, member of theranostic isotopes of Terbium1
Streamlined Synthesis of [18F]FSPG on the GE FASTlab™ 2 Platform for Preclinical and Clinical Applications1
Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl1
Quality Control of Therapeutic Radiopharmaceuticals: Assessment of Quality Control and In Vivo Biodistribution of Radiolysed [177Lu]Lu-PSMA-I&T1
A cassette-based process for the multidose production of [11C]Acetate on the AllinOne1
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications1
Development of Targeted Theranostics through Clinical Applicability Validation based on Pancreatic Cancer Patient-derived Organoid Platform1
A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben1
New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy1
43Sc and 44Sc radiolabelling of biomolecules and their use in PET imaging1
Synthesis of radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 11
Improving the quality of Ga radionuclides to achieve high radiolabeling yields1
CONTENTS1
Copper-mediated radiofluorination: A battle against protodeboronation1
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours1
In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK62401
Synthesis of a carbon-11 labeled metabotropic glutamate receptor 7 ligand for PET neuroimaging0
A 68Ga-labeled linear peptide-based PET radiotracers for imaging PD-L1 status in tumors0
0.050909996032715